Olmesartan Medoxomil and Hydrochlorothiazide

Product NDC
71335-0203
11-digit product format
713350203
Labeler code
71335
Product ID
71335-0203_de0cb1c2-df4e-41b0-85fd-d2e0f7633aa0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
olmesartan medoxomil-hydrochlorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
NDA021532
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2016-10-26
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Active strength
13 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71335-0203-17133502030130 TABLET, FILM COATED in 1 BOTTLE (71335-0203-1) 2016-10-260000-00-00NoNoCurrent
71335-0203-27133502030290 TABLET, FILM COATED in 1 BOTTLE (71335-0203-2) 2016-10-260000-00-00NoNoCurrent
71335-0203-37133502030328 TABLET, FILM COATED in 1 BOTTLE (71335-0203-3) 2016-10-260000-00-00NoNoCurrent